[Latest information on the treatment of uterine cervical cancer]
- PMID: 12214464
[Latest information on the treatment of uterine cervical cancer]
Abstract
We investigated the role of hemoglobin level in chemoradiation therapy for patients with advanced cervical cancer by reviewing the literature for current therapeutic information. We found that anemia during chemoradiation therapy is an important physiological factor in determining the long-term prognosis of patients with advanced cervical cancer.
Similar articles
-
[Anemia impact on treatments of cervical carcinomas].Cancer Radiother. 2005 Mar;9(2):87-95. doi: 10.1016/j.canrad.2005.01.004. Cancer Radiother. 2005. PMID: 15820436 Review. French.
-
[Hemoglobin level--a prognostic factor of the effectiveness of metronidazole in radiotherapy of cancer of the cervix uteri].Med Radiol (Mosk). 1986 Dec;31(12):16-9. Med Radiol (Mosk). 1986. PMID: 3540512 Clinical Trial. Russian.
-
Erythropoietin and radiotherapy: a dangerous combination?Strahlenther Onkol. 2004 Mar;180(3):133-5. Strahlenther Onkol. 2004. PMID: 15032246 No abstract available.
-
Recombinant human erythropoietin as an adjunct to radiation therapy and cisplatin for stage IIB-IVA carcinoma of the cervix: a Southwest Oncology Group study.Gynecol Oncol. 2004 Oct;95(1):145-51. doi: 10.1016/j.ygyno.2004.07.009. Gynecol Oncol. 2004. PMID: 15385124 Clinical Trial.
-
Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy?Oncologist. 2004;9 Suppl 5:31-40. doi: 10.1634/theoncologist.9-90005-31. Oncologist. 2004. PMID: 15591420 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical